Rapa was demonstrated to ameliorate energy homeostasis in cardiomyocytes via inactivation of NF-κB, thereby attenuating established cardiac hypertrophy after isoproterenol stimulation. The gene discussed is TRERF1; the disease is cardiac hypertrophy.